Prostate cancer Board decisions

The Veteran's TDIU claim is granted, but his diabetes mellitus rating remains remanded for further action.

The Board has granted service connection for asbestosis, restrictive/obstructive lung disease, and prostate cancer. The appeal regarding bladder cancer and cerebrovascular accident (CVA) is remanded.

The Board has determined that the issue of an increased rating for prostate cancer in excess of 40 percent is remanded due to inadequate examination and development needs. The propriety of the reduction in the rating for prostate cancer from 100 percent to 40 percent, effective July 1, 2013, and the SMC claim related to housebound status are not addressed as they were opted into the modernized review system.

The Veteran's appeal for a higher rating of prostate cancer and erectile dysfunction was denied. The Board found that there is no evidence of reoccurrence or metastasis, and the Veteran does not need to change absorbent materials more than twice per day for stress incontinence.

The Board has remanded the Veteran's claims for service connection due to conflicting evidence and need for further development. The claims include prostate cancer, hyperthyroidism, erectile dysfunction (secondary to prostate cancer), TBI, and depression.

The Board denied DIC benefits based on service connection for the cause of the Veteran's death, finding that fatigue from his prostate cancer treatment did not substantially or materially contribute to his death.

The Veteran's prostate cancer was in remission prior to October 19, 2016. From that date forward, his prostate cancer has been active and warrants a 100% rating.,Service connection for gynecomastia is granted as secondary to the service-connected prostate cancer.

The Board denied service connection for diabetes mellitus type 2 and prostate cancer associated with herbicide exposure, finding no in-service exposure to such agents.

The Veteran's claim for service connection for Other Traumatic Stressor Disorder with Anhedonia is granted. The claims for cardiovascular, gastrointestinal or genitourinary disabilities, and skin disability are remanded.

The Veteran's appeal is remanded for further development regarding his PTSD and prostate cancer claims.

The Board has remanded the cases for further investigation and to determine if service connection can be granted for prostate cancer, a higher disability rating for a lower right eyelid scar, and an earlier effective date for service connection of a lower right eyelid scar.

The Veteran's TDIU claim is dismissed because he is already receiving a 100% rating for prostate cancer and SMC at the housebound rate, which moots his need for TDIU.

The Veteran's erectile dysfunction is not service-connected and was denied. From October 15, 2018 to July 9, 2019, the Veteran received a 40 percent rating for his prostate cancer residuals due to voiding dysfunction. After December 6, 2019, he was denied an increased rating.

The Veteran withdrew his appeals for a rating in excess of 10 percent for a right thumb disability, an earlier effective date for a prostate cancer rating, and an earlier effective date for PTSD service connection. The Board dismissed the Legacy appeal as it was erroneously returned to review under the Legacy Appeals System.

The Veteran's prostate cancer was not found to be related to service, including exposure to ionizing radiation during Operation Wigwam in May 1955.

The Veteran's appeal was dismissed due to his death, and the Board has no jurisdiction to adjudicate the merits of this appeal.

The Veteran's prostate cancer is presumed to be associated with his conceded in-service herbicide agent exposure, and service connection for this disability is granted.

The Veteran's appeal is remanded for a higher rating and an earlier effective date for his service-connected residuals of prostate cancer to include incontinence.

The Veteran's claims for increased ratings for prostate cancer residuals and bilateral hearing loss were denied. The Veteran is already in receipt of the maximum schedular rating available for voiding dysfunction due to urinary incontinence, which is rated at 60 percent.

The Veteran's appeal to grant an earlier effective date for prostate cancer associated with herbicide exposure has been withdrawn, and the Board dismissed the case.